Gastrointestinal Pathogen Testing Market

Gastrointestinal Pathogen Testing Market (Pathogen Type: Bacteria, Viruses, and Parasites; Test Type: Molecular Tests, Culture, Biochemical Tests, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031

Global Gastrointestinal Pathogen Testing Market Outlook 2031

  • The industry was valued at US$ 4.0 Bn in 2022
  • It is projected to grow at a CAGR of 3.2% from 2023 to 2031 to reach more than US$ 5.2 Bn by the end of 2031

Analyst Viewpoint

Rise in prevalence of gastrointestinal infections is driving the global market. Gastrointestinal pathogens pose a substantial public health burden across the globe. Increase in need for advanced testing methods to detect and identify various pathogens responsible for gastrointestinal diseases is propelling market expansion. Furthermore, surge in demand for point-of-care (POC) testing is expected bolster the global gastrointestinal pathogen testing market size during the forecast period.

Focus on extensive research and development to expand existing clinical diagnostic applications offers lucrative opportunities to market players. Companies are focusing on enhancing diagnostic accuracy, reduce turnaround times, and improve overall efficiency in clinical laboratories in order to increase revenue.

However, high cost associated with advanced diagnostic technologies, need for skilled personnel, and regulatory hurdles are expected to restrain the global gastrointestinal pathogen testing market.

Gastrointestinal Pathogen Testing Market

Global Gastrointestinal Pathogen Testing Market Overview

Gastrointestinal (GI) pathogen testing is a diagnostic approach used to identify the specific microorganisms causing a gastrointestinal (GI) infection. These infections can be caused by various pathogens, including bacteria, viruses, and parasites, each with its own unique characteristics and treatment options.

Accurate diagnosis through GI pathogen testing is crucial for implementing effective treatment and preventing further spread of the infection. This type of testing is often recommended when individuals present with symptoms such as diarrhea, abdominal pain, nausea, vomiting, and fever. In healthcare settings, gastrointestinal pathogen testing is crucial for diagnosing and managing infectious gastroenteritis, food poisoning, and other gastrointestinal infections.

Advances in technology have led to the development of multiplex panels that allow simultaneous detection of multiple pathogens in a single test. These panels enhance the efficiency of diagnosis by providing comprehensive results in a shorter time frame. They are especially beneficial in cases where multiple pathogens could be responsible for the symptoms.

The testing process also aids in monitoring antimicrobial resistance patterns among gastrointestinal pathogens. Understanding the resistance profiles of these microorganisms is vital for guiding appropriate antibiotic therapy and addressing the global concern of antimicrobial resistance.

Rise in Incidence of Gastrointestinal Disorders

Surge in gastrointestinal disorders is fueling the global gastrointestinal pathogen testing market growth. Various gastrointestinal issues such as infections, inflammations, functional disorders, and cancers have been rising globally due to changing lifestyles, dietary changes, environmental influences, and an aging population.

Bacterial, viral, and parasitic infections contribute to acute conditions such as diarrhea, food poisoning, and gastroenteritis, thus driving the need for effective pathogen testing methods.

Chronic conditions such as inflammatory bowel disease (IBD), Crohn's disease, ulcerative colitis, and colorectal cancer pose significant health risks. The need for precise and early diagnosis of these disorders drives demand for accurate and efficient diagnostic tools capable of identifying specific pathogens responsible for these ailments.

According to the World Health Organization (WHO), digestive diseases are responsible for 700,000 deaths annually, making them the third leading cause of death across the world. The WHO also reports that one in five people globally experience digestive problems each year. A 2022 study published in The Lancet estimated that the global burden of digestive diseases will increase by 35% by 2040, driven by population growth and aging.

This escalation in gastrointestinal disorders has prompted increased emphasis on the development and adoption of advanced testing methods, including molecular diagnostics, point-of-care testing, and non-invasive diagnostic techniques. This, in turn, is expected to propel the global gastrointestinal pathogen testing market demand.

Increase in Demand for Point-of-Care (POC) Testing Bolstering Market Growth

POC testing offers rapid and accurate diagnosis at the patient's bedside or in outpatient settings, enabling immediate initiation of treatment. In the realm of gastrointestinal disorders, quick and precise identification of pathogens causing infections or illnesses such as diarrhea, gastroenteritis, and other digestive tract disorders is crucial for timely intervention.

The convenience and speed offered by POC tests, providing real-time results without the need for centralized laboratory infrastructure, are particularly advantageous in remote or resource-limited settings where immediate diagnosis and treatment decisions are imperative.

These tests often utilize innovative technologies such as molecular assays, immunoassays, or microfluidics, allowing for efficient detection of a broad spectrum of gastrointestinal pathogens.

Thus, surge in adoption of POC testing, driven by portability, ease of use, and accuracy, is propelling the gastrointestinal pathogen testing market revenue.

High Sensitivity and Specificity Driving Demand for Molecular Tests

In terms of test type, the molecular tests segment is projected to dominate the global gastrointestinal pathogen testing industry during the forecast period.

Molecular tests are known for their high sensitivity and specificity, allowing for accurate detection of nucleic acids specific to pathogens. The ability to detect low levels of genetic material contributes to early and precise diagnosis, even in cases with low pathogen concentrations.

Molecular tests can be designed to detect multiple pathogens simultaneously in a single assay. This capability is particularly valuable in diagnosing gastrointestinal infections where various pathogens, including bacteria, viruses, and parasites, may be responsible for similar clinical symptoms.

Technological advancements and new product launch are likely to drive the molecular tests segment during the forecast period. For instance, in April 2023, Molecular Designs, a developer and manufacturer of molecular infectious disease assays, announced the release of its new Simplicity Gastrointestinal Pathogen Panel for the detection of causative agents of gastrointestinal (GI) tract infections.

Regional Outlook

North America is anticipated to account for the largest global gastrointestinal pathogen testing market share during the forecast period. The region, particularly the U.S. and Canada, boasts a highly advanced healthcare infrastructure with well-established healthcare systems, numerous hospitals, and a network of diagnostic laboratories. This infrastructure supports efficient and widespread access to gastrointestinal pathogen testing.

Prevalence of gastrointestinal infections is relatively high in North America. Factors such as population density, travel-related exposures, and lifestyle contribute to substantial demand for gastrointestinal pathogen testing. According to CDC estimates, each year around 1 in 6 persons in the U.S. (or 48 million people) gets sick, 128,000 are hospitalized, and 3,000 succumb to foodborne illnesses.

As per gastrointestinal pathogen testing market analysis, the industry in Asia Pacific is likely to expand at the fastest CAGR during the forecast period. The region experiences a significant burden of gastrointestinal infections due to factors such as population density, water and foodborne diseases, and environmental conditions. High prevalence of these infections increases the demand for diagnostic testing.

Asia Pacific is witnessing advancements in diagnostic technologies, including molecular testing methods and automation. Adoption of these technologies is contributing to the growth of the gastrointestinal pathogen testing market in the region. In 2021, around 1.33 million cases of infectious diarrhea were registered in China, making it the second-most common communicable disease after hand-foot-mouth disease in the country that year.

Analysis of Key Players

This report provides profiles of leading players operating in the global gastrointestinal pathogen testing market. These players engage in mergers & acquisitions, strategic collaborations, and new product launches to expand market presence.

bioMérieux SA, Becton, Dickinson, and Company (BD), QIAGEN, Bio-Rad Laboratories, Inc., Thermo Fisher Scientific, Inc., Meridian Bioscience, Inc., Cepheid (Danaher Corporation), Laboratory Corporation of America Holdings, Illumina, Inc., DiaSorin S.p.A., Seegene, Inc., CerTest Biotec, S.L., Abbott, F. Hoffmann-La Roche Ltd., Genova Diagnostics, MicroGen DX, and Quidel Corporation are the prominent players in the global gastrointestinal pathogen testing market.

Key Developments in Global Gastrointestinal Pathogen Testing Market

  • In October 2023, Oxford Nanopore Technologies plc, known for its innovative nanopore-based molecular sensing tech, partnered with bioMérieux SA, a leader in in vitro diagnostics. This collaboration involves an investment by bioMérieux in Oxford Nanopore. The aim is to capitalize on Oxford Nanopore's pioneering nanopore-based IVD solution, combining it with bioMérieux's expertise in R&D, regulatory affairs, medical, and market access within the IVD field.
  • In September 2023, a global leader in services for the scientific community, Springer Nature, and Seegene, Inc., which offers a comprehensive solution for PCR molecular diagnostics, jointly presented the "Open Innovation Program powered by Seegene. The first program, which is accessible everywhere, aims to enable professionals, scientists, and physicians to create syndromic quantitative PCR (qPCR) experiments in any field.

The gastrointestinal pathogen testing market report profiles the top players based on various factors such as a company overview, financial summary, strategies, product portfolio, segments, and recent advancements.

Global Gastrointestinal Pathogen Testing Market Snapshot

Attribute Detail
Size in 2022 US$ 4.0 Bn
Forecast (Value) in 2031 More than US$ 5.2 Bn
Growth Rate (CAGR) 3.2%
Forecast Period 2023-2031
Historical Data Available for 2017-2022
Quantitative Units US$ Bn for Value
Market Analysis It includes segment analysis as well as regional-level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces analysis, value chain analysis, and key trend analysis.
Competition Landscape
  • Market share analysis by company (2022)
  • Company profiles section includes an overview, product portfolio, sales footprint, key subsidiaries or distributors, strategy & recent developments, and key financials
Format Electronic (PDF) + Excel
Segmentation
  • Pathogen Type
    • Bacteria
      • Molecular Tests
      • Culture
      • Biochemical Tests
      • Others
    • Viruses
      • Molecular Tests
      • Culture
      • Others
    • Parasites
      • Ova and Parasite Microscopy
      • Molecular Tests
      • Others
  • Test Type
    • Molecular Tests
    • Culture
    • Biochemical Tests
    • Others
  • Panel Type
    • Syndromic Full Multiplex Panels
    • Others
  • End-user
    • Hospitals
      • Public
      • Private
      • Others
    • Diagnostic Laboratories
    • Point-of-Care
    • Others
Regions Covered
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa
Countries Covered
  • U.S.
  • Canada
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • China
  • India
  • Japan
  • Australia & New Zealand
  • Brazil
  • Mexico
  • GCC Countries
  • South Africa
Companies Profiled
  • bioMérieux SA
  • Becton, Dickinson, and Company (BD)
  • QIAGEN
  • Bio-Rad Laboratories, Inc.
  • Thermo Fisher Scientific, Inc.
  • Meridian Bioscience, Inc.
  • Cepheid (Danaher Corporation)
  • Laboratory Corporation of America Holdings
  • Illumina, Inc.
  • DiaSorin S.p.A.
  • Seegene, Inc.
  • CerTest Biotec, S.L.
  • Abbott
  • F. Hoffmann-La Roche Ltd.
  • Genova Diagnostics
  • MicroGen DX
  • Quidel Corporation
Customization Scope Available upon request
Pricing Available upon request

Frequently Asked Questions

How big was the global gastrointestinal pathogen testing market in 2022?

It was valued at US$ 4.0 Bn in 2022

How big will the gastrointestinal pathogen testing business be in 2031?

It is projected to reach more than US$ 5.2 Bn by 2031

What will the CAGR of the gastrointestinal pathogen testing industry be during the forecast period?

The CAGR is anticipated to be 3.2% from 2023 to 2031

What was the leading gastrointestinal pathogen testing segment in 2022?

The molecular tests segment accounted for the largest share in 2022

Which region will account for major share of the gastrointestinal pathogen testing sector during the forecast period?

North America is expected to account for the leading share during the forecast period.

Who are the prominent providers of gastrointestinal pathogen testing?

bioMérieux SA, Becton, Dickinson, and Company (BD), QIAGEN, Bio-Rad Laboratories, Inc., Thermo Fisher Scientific, Inc., Meridian Bioscience, Inc., Cepheid (Danaher Corporation), Laboratory Corporation of America Holdings, Illumina, Inc., DiaSorin S.p.A., Seegene, Inc., CerTest Biotec, S.L., Abbott, F. Hoffmann-La Roche Ltd., Genova Diagnostics, MicroGen DX, and Quidel Corporation.

1. Preface

    1.1. Market Definition and Scope

    1.2. Market Segmentation

    1.3. Key Research Objectives

    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Gastrointestinal Pathogen Testing Market

4. Market Overview

    4.1. Overview

    4.2. Market Dynamics

        4.2.1. Drivers

        4.2.2. Restraints

        4.2.3. Opportunities

    4.3. Global Gastrointestinal Pathogen Testing Market Value Analysis and Forecast, 2017–2031

5. Key Insights

    5.1. Gastrointestinal Disorders: Overview

    5.2. Technological Advancements

    5.3. Key Industry Events (Key Developments, Partnership, Collaborations etc.)

    5.4. Overview of the test type conducted across each of the End users

    5.5. COVID-19 Pandemic Impact on Industry

6. Global Gastrointestinal Pathogen Testing Market Analysis, by Pathogen Type

    6.1. Introduction

    6.2. Global Gastrointestinal Pathogen Testing Market Share Analysis, by Pathogen Type

    6.3. Global Gastrointestinal Pathogen Testing Market Attractiveness Analysis, by Pathogen Type

    6.4. Global Gastrointestinal Pathogen Testing Market Analysis, by Pathogen Type

    6.5. Global Gastrointestinal Pathogen Testing Market Forecast, by Pathogen Type

        6.5.1. Bacteria

            6.5.1.1. Molecular Tests

            6.5.1.2. Culture

            6.5.1.3. Biochemical Tests

            6.5.1.4. Others

        6.5.2. Viruses

            6.5.2.1. Molecular Tests

            6.5.2.2. Culture

            6.5.2.3. Others

        6.5.3. Parasites

            6.5.3.1. Ova and Parasite Microscopy

            6.5.3.2. Molecular Tests

            6.5.3.3. Others

7. Global Gastrointestinal Pathogen Testing Market Analysis, by Test Type

    7.1. Introduction

    7.2. Global Gastrointestinal Pathogen Testing Market Share Analysis, by Test Type

    7.3. Global Gastrointestinal Pathogen Testing Market Attractiveness Analysis, by Test Type

    7.4. Global Gastrointestinal Pathogen Testing Market Analysis, by Test Type

    7.5. Global Gastrointestinal Pathogen Testing Market Forecast, by Test Type

        7.5.1. Molecular Tests

        7.5.2. Culture

        7.5.3. Biochemical Tests

        7.5.4. Others

8. Global Gastrointestinal Pathogen Testing Market Analysis, by Panel Type

    8.1. Introduction

    8.2. Global Gastrointestinal Pathogen Testing Market Share Analysis, by Panel Type

    8.3. Global Gastrointestinal Pathogen Testing Market Attractiveness Analysis, by Panel Type

    8.4. Global Gastrointestinal Pathogen Testing Market Analysis, by Panel Type

    8.5. Global Gastrointestinal Pathogen Testing Market Forecast, by Panel Type

        8.5.1. Syndromic Full Multiplex Panels

        8.5.2. Others

9. Global Gastrointestinal Pathogen Testing Market Analysis, by End-user

    9.1. Introduction

    9.2. Global Gastrointestinal Pathogen Testing Market Share Analysis, by End-user

    9.3. Global Gastrointestinal Pathogen Testing Market Attractiveness Analysis, by End-user

    9.4. Global Gastrointestinal Pathogen Testing Market Analysis, by End-user

    9.5. Global Gastrointestinal Pathogen Testing Market Forecast, by End-user

        9.5.1. Hospitals

            9.5.1.1. Public

            9.5.1.2. Private

            9.5.1.3. Others

        9.5.2. Diagnostic Laboratories

        9.5.3. Point-of-Care

        9.5.4. Others

10. Global Gastrointestinal Pathogen Testing Market Analysis, by Region

    10.1. Introduction

    10.2. Global Gastrointestinal Pathogen Testing Market Share Analysis, by Region

    10.3. Global Gastrointestinal Pathogen Testing Market Attractiveness Analysis, by Region

    10.4. Global Gastrointestinal Pathogen Testing Market Forecast, by Region

        10.4.1. North America

        10.4.2. Europe

        10.4.3. Asia Pacific

        10.4.4. Latin America

        10.4.5. Middle East & Africa

11. North America Gastrointestinal Pathogen Testing Market Analysis

    11.1. Key Insights: North America Gastrointestinal Pathogen Testing Market

    11.2. North America Gastrointestinal Pathogen Testing Market Overview

    11.3. North America Gastrointestinal Pathogen Testing Market Forecast, by Country

        11.3.1. U.S.

        11.3.2. Canada

    11.4. North America Gastrointestinal Pathogen Testing Market Share & Attractiveness Analysis, by Pathogen Type

    11.5. North America Gastrointestinal Pathogen Testing Market Forecast, by Pathogen Type

        11.5.1. Bacteria

            11.5.1.1. Molecular Tests

            11.5.1.2. Culture

            11.5.1.3. Biochemical Tests

            11.5.1.4. Others

        11.5.2. Viruses

            11.5.2.1. Molecular Tests

            11.5.2.2. Culture

            11.5.2.3. Others

        11.5.3. Parasites

            11.5.3.1. Ova and Parasite Microscopy

            11.5.3.2. Molecular Tests

            11.5.3.3. Others

    11.6. North America Gastrointestinal Pathogen Testing Market Share & Attractiveness Analysis, by Test Type

    11.7. North America Gastrointestinal Pathogen Testing Market Forecast, by Test Type

        11.7.1. Molecular Tests

        11.7.2. Culture

        11.7.3. Biochemical Tests

        11.7.4. Others

    11.8. North America Gastrointestinal Pathogen Testing Market Share & Attractiveness Analysis, by Panel Type

    11.9. North America Gastrointestinal Pathogen Testing Market Forecast, by Panel Type

        11.9.1. Syndromic Full Multiplex Panels

        11.9.2. Others

    11.10. North America Gastrointestinal Pathogen Testing Market Share & Attractiveness Analysis, by End-user

    11.11. North America Gastrointestinal Pathogen Testing Market Forecast, by End-user

        11.11.1. Hospitals

            11.11.1.1. Public

            11.11.1.2. Private

            11.11.1.3. Others

        11.11.2. Diagnostic Laboratories

        11.11.3. Point-of-Care

        11.11.4. Others

12. Europe Gastrointestinal Pathogen Testing Market Analysis

    12.1. Key Insights: Europe Gastrointestinal Pathogen Testing Market

    12.2. Europe Gastrointestinal Pathogen Testing Market Overview

    12.3. Europe Gastrointestinal Pathogen Testing Market Forecast, by Country/Sub-region

        12.3.1. Germany

        12.3.2. U.K.

        12.3.3. France

        12.3.4. Italy

        12.3.5. Spain

        12.3.6. Rest of Europe

    12.4. Europe Gastrointestinal Pathogen Testing Market Share & Attractiveness Analysis, by Pathogen Type

    12.5. Europe Gastrointestinal Pathogen Testing Market Forecast, by Pathogen Type

        12.5.1. Bacteria

            12.5.1.1. Molecular Tests

            12.5.1.2. Culture

            12.5.1.3. Biochemical Tests

            12.5.1.4. Others

        12.5.2. Viruses

            12.5.2.1. Molecular Tests

            12.5.2.2. Culture

            12.5.2.3. Others

        12.5.3. Parasites

            12.5.3.1. Ova and Parasite Microscopy

            12.5.3.2. Molecular Tests

            12.5.3.3. Others

    12.6. Europe Gastrointestinal Pathogen Testing Market Share & Attractiveness Analysis, by Test Type

    12.7. Europe Gastrointestinal Pathogen Testing Market Forecast, by Test Type

        12.7.1. Molecular Tests

        12.7.2. Culture

        12.7.3. Biochemical Tests

        12.7.4. Others

    12.8. Europe Gastrointestinal Pathogen Testing Market Share & Attractiveness Analysis, by Panel Type

    12.9. Europe Gastrointestinal Pathogen Testing Market Forecast, by Panel Type

        12.9.1. Syndromic Full Multiplex Panels

        12.9.2. Others

    12.10. Europe Gastrointestinal Pathogen Testing Market Share & Attractiveness Analysis, by End-user

    12.11. Europe Gastrointestinal Pathogen Testing Market Forecast, by End-user

        12.11.1. Hospitals

            12.11.1.1. Public

            12.11.1.2. Private

            12.11.1.3. Others

        12.11.2. Diagnostic Laboratories

        12.11.3. Point-of-Care

        12.11.4. Others

13. Asia Pacific Gastrointestinal Pathogen Testing Market Analysis

    13.1. Key Insights: Asia Pacific Gastrointestinal Pathogen Testing Market

    13.2. Asia Pacific Gastrointestinal Pathogen Testing Market Overview

    13.3. Asia Pacific Gastrointestinal Pathogen Testing Market Forecast, by Country/Sub-region

        13.3.1. China

        13.3.2. Japan

        13.3.3. India

        13.3.4. Australia & New Zealand

        13.3.5. Rest of Asia Pacific

    13.4. Asia Pacific Gastrointestinal Pathogen Testing Market Share & Attractiveness Analysis, by Pathogen Type

    13.5. Asia Pacific Gastrointestinal Pathogen Testing Market Forecast, by Pathogen Type

        13.5.1. Bacteria

            13.5.1.1. Molecular Tests

            13.5.1.2. Culture

            13.5.1.3. Biochemical Tests

            13.5.1.4. Others

        13.5.2. Viruses

            13.5.2.1. Molecular Tests

            13.5.2.2. Culture

            13.5.2.3. Others

        13.5.3. Parasites

            13.5.3.1. Ova and Parasite Microscopy

            13.5.3.2. Molecular Tests

            13.5.3.3. Others

    13.6. Asia Pacific Gastrointestinal Pathogen Testing Market Share & Attractiveness Analysis, by Test Type

    13.7. Asia Pacific Gastrointestinal Pathogen Testing Market Forecast, by Test Type

        13.7.1. Molecular Tests

        13.7.2. Culture

        13.7.3. Biochemical Tests

        13.7.4. Others

    13.8. Asia Pacific Gastrointestinal Pathogen Testing Market Share & Attractiveness Analysis, by Panel Type

    13.9. Asia Pacific Gastrointestinal Pathogen Testing Market Forecast, by Panel Type

        13.9.1. Syndromic Full Multiplex Panels

        13.9.2. Others

    13.10. Asia Pacific Gastrointestinal Pathogen Testing Market Share & Attractiveness Analysis, by End-user

    13.11. Asia Pacific Gastrointestinal Pathogen Testing Market Forecast, by End-user

        13.11.1. Hospitals

            13.11.1.1. Public

            13.11.1.2. Private

            13.11.1.3. Others

        13.11.2. Diagnostic Laboratories

        13.11.3. Point-of-Care

        13.11.4. Others

14. Latin America Gastrointestinal Pathogen Testing Market Analysis

    14.1. Key Insights: Latin America Gastrointestinal Pathogen Testing Market

    14.2. Latin America Gastrointestinal Pathogen Testing Market Overview

    14.3. Latin America Gastrointestinal Pathogen Testing Market Forecast, by Country/Sub-region

        14.3.1. Brazil

        14.3.2. Mexico

        14.3.3. Rest of Latin America

    14.4. Latin America Gastrointestinal Pathogen Testing Market Share & Attractiveness Analysis, by Pathogen Type

    14.5. Latin America Gastrointestinal Pathogen Testing Market Forecast, by Pathogen Type

        14.5.1. Bacteria

            14.5.1.1. Molecular Tests

            14.5.1.2. Culture

            14.5.1.3. Biochemical Tests

            14.5.1.4. Others

        14.5.2. Viruses

            14.5.2.1. Molecular Tests

            14.5.2.2. Culture

            14.5.2.3. Others

        14.5.3. Parasites

            14.5.3.1. Ova and Parasite Microscopy

            14.5.3.2. Molecular Tests

            14.5.3.3. Others

    14.6. Latin America Gastrointestinal Pathogen Testing Market Share & Attractiveness Analysis, by Test Type

    14.7. Latin America Gastrointestinal Pathogen Testing Market Forecast, by Test Type

        14.7.1. Molecular Tests

        14.7.2. Culture

        14.7.3. Biochemical Tests

        14.7.4. Others

    14.8. Latin America Gastrointestinal Pathogen Testing Market Share & Attractiveness Analysis, by Panel Type

    14.9. Latin America Gastrointestinal Pathogen Testing Market Forecast, by Panel Type

        14.9.1. Syndromic Full Multiplex Panels

        14.9.2. Others

    14.10. Latin America Gastrointestinal Pathogen Testing Market Share & Attractiveness Analysis, by End-user

    14.11. Latin America Gastrointestinal Pathogen Testing Market Forecast, by End-user

        14.11.1. Hospitals

            14.11.1.1. Public

            14.11.1.2. Private

            14.11.1.3. Others

        14.11.2. Diagnostic Laboratories

        14.11.3. Point-of-Care

        14.11.4. Others

15. Middle East & Africa Gastrointestinal Pathogen Testing Market Analysis

    15.1. Key Insights: Middle East & Africa Gastrointestinal Pathogen Testing Market

    15.2. Middle East & Africa Gastrointestinal Pathogen Testing Market Overview

    15.3. Middle East & Africa Gastrointestinal Pathogen Testing Market Forecast, by Country/Sub-region

        15.3.1. GCC Countries

        15.3.2. South Africa

        15.3.3. Rest of Middle East & Africa

    15.4. Middle East & Africa Gastrointestinal Pathogen Testing Market Share & Attractiveness Analysis, by Pathogen Type

    15.5. Middle East & Africa Gastrointestinal Pathogen Testing Market Forecast, by Pathogen Type

        15.5.1. Bacteria

            15.5.1.1. Molecular Tests

            15.5.1.2. Culture

            15.5.1.3. Biochemical Tests

            15.5.1.4. Others

        15.5.2. Viruses

            15.5.2.1. Molecular Tests

            15.5.2.2. Culture

            15.5.2.3. Others

        15.5.3. Parasites

            15.5.3.1. Ova and Parasite Microscopy

            15.5.3.2. Molecular Tests

            15.5.3.3. Others

    15.6. Middle East & Africa Gastrointestinal Pathogen Testing Market Share & Attractiveness Analysis, by Test Type

    15.7. Middle East & Africa Gastrointestinal Pathogen Testing Market Forecast, by Test Type

        15.7.1. Molecular Tests

        15.7.2. Culture

        15.7.3. Biochemical Tests

        15.7.4. Others

    15.8. Middle East & Africa Gastrointestinal Pathogen Testing Market Share & Attractiveness Analysis, by Panel Type

    15.9. Middle East & Africa Gastrointestinal Pathogen Testing Market Forecast, by Panel Type

        15.9.1. Syndromic Full Multiplex Panels

        15.9.2. Others

    15.10. Middle East & Africa Gastrointestinal Pathogen Testing Market Share & Attractiveness Analysis, by End-user

    15.11. Middle East & Africa Gastrointestinal Pathogen Testing Market Forecast, by End-user

        15.11.1. Hospitals

            15.11.1.1. Public

            15.11.1.2. Private

            15.11.1.3. Others

        15.11.2. Diagnostic Laboratories

        15.11.3. Point-of-Care

        15.11.4. Others

16. Competition Landscape

    16.1. Market Player – Competition Matrix (by tier and size of companies)

    16.2. Market Share Analysis, by Company (2022)

    16.3. Company Profiles

        16.3.1. bioMérieux SA

            16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.3.1.2. Product Portfolio

            16.3.1.3. Financial Overview

            16.3.1.4. SWOT Analysis

            16.3.1.5. Strategic Overview

        16.3.2. Becton, Dickinson, and Company (BD)

            16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.3.2.2. Product Portfolio

            16.3.2.3. Financial Overview

            16.3.2.4. SWOT Analysis

            16.3.2.5. Strategic Overview

        16.3.3. QIAGEN

            16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.3.3.2. Product Portfolio

            16.3.3.3. Financial Overview

            16.3.3.4. SWOT Analysis

            16.3.3.5. Strategic Overview

        16.3.4. Bio-Rad Laboratories, Inc.

            16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.3.4.2. Product Portfolio

            16.3.4.3. Financial Overview

            16.3.4.4. SWOT Analysis

            16.3.4.5. Strategic Overview

        16.3.5. Thermo Fisher Scientific, Inc.

            16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.3.5.2. Product Portfolio

            16.3.5.3. Financial Overview

            16.3.5.4. SWOT Analysis

            16.3.5.5. Strategic Overview

        16.3.6. Meridian Bioscience, Inc.

            16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.3.6.2. Product Portfolio

            16.3.6.3. Financial Overview

            16.3.6.4. SWOT Analysis

            16.3.6.5. Strategic Overview

        16.3.7. Cepheid (Danaher Corporation)

            16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.3.7.2. Product Portfolio

            16.3.7.3. Financial Overview

            16.3.7.4. SWOT Analysis

            16.3.7.5. Strategic Overview

        16.3.8. Laboratory Corporation of America Holdings

            16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.3.8.2. Product Portfolio

            16.3.8.3. Financial Overview

            16.3.8.4. SWOT Analysis

            16.3.8.5. Strategic Overview

        16.3.9. Illumina, Inc.

            16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.3.9.2. Product Portfolio

            16.3.9.3. Financial Overview

            16.3.9.4. SWOT Analysis

            16.3.9.5. Strategic Overview

        16.3.10. DiaSorin S.p.A.

            16.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.3.10.2. Product Portfolio

            16.3.10.3. Financial Overview

            16.3.10.4. SWOT Analysis

            16.3.10.5. Strategic Overview

        16.3.11. Seegene, Inc.

            16.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.3.11.2. Product Portfolio

            16.3.11.3. Financial Overview

            16.3.11.4. SWOT Analysis

            16.3.11.5. Strategic Overview

        16.3.12. CerTest Biotec, S.L.

            16.3.12.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.3.12.2. Product Portfolio

            16.3.12.3. Financial Overview

            16.3.12.4. SWOT Analysis

            16.3.12.5. Strategic Overview

        16.3.13. Abbott

            16.3.13.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.3.13.2. Product Portfolio

            16.3.13.3. Financial Overview

            16.3.13.4. SWOT Analysis

            16.3.13.5. Strategic Overview

        16.3.14. F. Hoffmann-La Roche Ltd.

            16.3.14.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.3.14.2. Product Portfolio

            16.3.14.3. Financial Overview

            16.3.14.4. SWOT Analysis

            16.3.14.5. Strategic Overview

        16.3.15. Genova Diagnostics

            16.3.15.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.3.15.2. Product Portfolio

            16.3.15.3. Financial Overview

            16.3.15.4. SWOT Analysis

            16.3.15.5. Strategic Overview

        16.3.16. MicroGen DX

            16.3.16.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.3.16.2. Product Portfolio

            16.3.16.3. Financial Overview

            16.3.16.4. SWOT Analysis

            16.3.16.5. Strategic Overview

        16.3.17. Quidel Corporation

            16.3.17.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.3.17.2. Product Portfolio

            16.3.17.3. Financial Overview

            16.3.17.4. SWOT Analysis

            16.3.17.5. Strategic Overview

List of Tables

Table 01: Global Gastrointestinal Pathogen Testing Market Value (US$ Mn) Forecast, by Pathogen Type, 2017-2031

Table 02: Global Gastrointestinal Pathogen Testing Market Value (US$ Mn) Forecast, by Bacteria, 2017-2031

Table 03: Global Gastrointestinal Pathogen Testing Market Value (US$ Mn) Forecast, by Viruses, 2017-2031

Table 04: Global Gastrointestinal Pathogen Testing Market Value (US$ Mn) Forecast, by Parasites, 2017-2031

Table 05: Global Gastrointestinal Pathogen Testing Market Value (US$ Mn) Forecast, by Test Type, 2017-2031

Table 06: Global Gastrointestinal Pathogen Testing Market Value (US$ Mn) Forecast, by Panel Type, 2017-2031

Table 07: Global Gastrointestinal Pathogen Testing Market Value (US$ Mn) Forecast, by End-user, 2017-2031

Table 08: Global Gastrointestinal Pathogen Testing Market Value (US$ Mn) Forecast, by Hospitals, 2017-2031

Table 09: Global Gastrointestinal Pathogen Testing Market Value (US$ Mn) Forecast, by Region, 2017-2031

Table 10: North America Gastrointestinal Pathogen Testing Market Value (US$ Mn) Forecast, by Country, 2017-2031

Table 11: North America Gastrointestinal Pathogen Testing Market Value (US$ Mn) Forecast, by Pathogen Type, 2017-2031

Table 12: North America Gastrointestinal Pathogen Testing Market Value (US$ Mn) Forecast, by Bacteria, 2017-2031

Table 13: North America Gastrointestinal Pathogen Testing Market Value (US$ Mn) Forecast, by Viruses, 2017-2031

Table 14: North America Gastrointestinal Pathogen Testing Market Value (US$ Mn) Forecast, by Parasites, 2017-2031

Table 15: North America Gastrointestinal Pathogen Testing Market Value (US$ Mn) Forecast, by Test Type, 2017-2031

Table 16: North America Gastrointestinal Pathogen Testing Market Value (US$ Mn) Forecast, by Panel Type, 2017-2031

Table 17: North America Gastrointestinal Pathogen Testing Market Value (US$ Mn) Forecast, by End-user, 2017-2031

Table 18: North America Gastrointestinal Pathogen Testing Market Value (US$ Mn) Forecast, by Hospitals, 2017-2031

Table 19: Europe Gastrointestinal Pathogen Testing Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031

Table 20: Europe Gastrointestinal Pathogen Testing Market Value (US$ Mn) Forecast, by Pathogen Type, 2017-2031

Table 21: Europe Gastrointestinal Pathogen Testing Market Value (US$ Mn) Forecast, by Bacteria, 2017-2031

Table 22: Europe Gastrointestinal Pathogen Testing Market Value (US$ Mn) Forecast, by Viruses, 2017-2031

Table 23: Europe Gastrointestinal Pathogen Testing Market Value (US$ Mn) Forecast, by Parasites, 2017-2031

Table 24: Europe Gastrointestinal Pathogen Testing Market Value (US$ Mn) Forecast, by Test Type, 2017-2031

Table 25: Europe Gastrointestinal Pathogen Testing Market Value (US$ Mn) Forecast, by Panel Type, 2017-2031

Table 26: Europe Gastrointestinal Pathogen Testing Market Value (US$ Mn) Forecast, by End-user, 2017-2031

Table 27: Europe Gastrointestinal Pathogen Testing Market Value (US$ Mn) Forecast, by Hospitals, 2017-2031

Table 28: Asia Pacific Gastrointestinal Pathogen Testing Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031

Table 29: Asia Pacific Gastrointestinal Pathogen Testing Market Value (US$ Mn) Forecast, by Pathogen Type, 2017-2031

Table 30: Asia Pacific Gastrointestinal Pathogen Testing Market Value (US$ Mn) Forecast, by Bacteria, 2017-2031

Table 31: Asia Pacific Gastrointestinal Pathogen Testing Market Value (US$ Mn) Forecast, by Viruses, 2017-2031

Table 32: Asia Pacific Gastrointestinal Pathogen Testing Market Value (US$ Mn) Forecast, by Parasites, 2017-2031

Table 33: Asia Pacific Gastrointestinal Pathogen Testing Market Value (US$ Mn) Forecast, by Test Type, 2017-2031

Table 34: Asia Pacific Gastrointestinal Pathogen Testing Market Value (US$ Mn) Forecast, by Panel Type, 2017-2031

Table 35: Asia Pacific Gastrointestinal Pathogen Testing Market Value (US$ Mn) Forecast, by End-user, 2017-2031

Table 36: Asia Pacific Gastrointestinal Pathogen Testing Market Value (US$ Mn) Forecast, by Hospitals, 2017-2031

Table 37: Latin America Gastrointestinal Pathogen Testing Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031

Table 38: Latin America Gastrointestinal Pathogen Testing Market Value (US$ Mn) Forecast, by Pathogen Type, 2017-2031

Table 39: Latin America Gastrointestinal Pathogen Testing Market Value (US$ Mn) Forecast, by Bacteria, 2017-2031

Table 40: Latin America Gastrointestinal Pathogen Testing Market Value (US$ Mn) Forecast, by Viruses, 2017-2031

Table 41: Latin America Gastrointestinal Pathogen Testing Market Value (US$ Mn) Forecast, by Parasites, 2017-2031

Table 42: Latin America Gastrointestinal Pathogen Testing Market Value (US$ Mn) Forecast, by Test Type, 2017-2031

Table 43: Latin America Gastrointestinal Pathogen Testing Market Value (US$ Mn) Forecast, by Panel Type, 2017-2031

Table 44: Latin America Gastrointestinal Pathogen Testing Market Value (US$ Mn) Forecast, by End-user, 2017-2031

Table 45: Latin America Gastrointestinal Pathogen Testing Market Value (US$ Mn) Forecast, by Hospitals, 2017-2031

Table 46: Middle East & Africa Gastrointestinal Pathogen Testing Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031

Table 47: Middle East & Africa Gastrointestinal Pathogen Testing Market Value (US$ Mn) Forecast, by Pathogen Type, 2017-2031

Table 48: Middle East & Africa Gastrointestinal Pathogen Testing Market Value (US$ Mn) Forecast, by Bacteria, 2017-2031

Table 49: Middle East & Africa Gastrointestinal Pathogen Testing Market Value (US$ Mn) Forecast, by Viruses, 2017-2031

Table 50: Middle East & Africa Gastrointestinal Pathogen Testing Market Value (US$ Mn) Forecast, by Parasites, 2017-2031

Table 51: Middle East & Africa Gastrointestinal Pathogen Testing Market Value (US$ Mn) Forecast, by Test Type, 2017-2031

Table 52: Middle East & Africa Gastrointestinal Pathogen Testing Market Value (US$ Mn) Forecast, by Panel Type, 2017-2031

Table 53: Middle East & Africa Gastrointestinal Pathogen Testing Market Value (US$ Mn) Forecast, by End-user, 2017-2031

Table 54: Middle East & Africa Gastrointestinal Pathogen Testing Market Value (US$ Mn) Forecast, by Hospitals, 2017-2031

List of Figures

Figure 01: Global Gastrointestinal Pathogen Testing Market Size, by Pathogen Type, 2022

Figure 02: Gastrointestinal Pathogen Testing Market Share (%), by Pathogen Type, 2022

Figure 03: Global Gastrointestinal Pathogen Testing Market Size, by Test Type, 2022

Figure 04: Gastrointestinal Pathogen Testing Market Share (%), by Test Type, 2022

Figure 05: Global Gastrointestinal Pathogen Testing Market Size, by Panel Type, 2022

Figure 06: Gastrointestinal Pathogen Testing Market Share (%), by Panel Type, 2022

Figure 07: Global Gastrointestinal Pathogen Testing Market Size, by End-user, 2022

Figure 08: Gastrointestinal Pathogen Testing Market Share (%), by End-user, 2022

Figure 09: Global Gastrointestinal Pathogen Testing Market, by Region (2022 and 2031)

Figure 10: Global Gastrointestinal Pathogen Testing Market Value (US$ Mn) Forecast, 2017–2031

Figure 11: Global Gastrointestinal Pathogen Testing Market Value (US$ Mn) Share Analysis, by Pathogen Type, 2022 and 2031

Figure 12: Global Gastrointestinal Pathogen Testing Market Value (US$ Mn) Share Analysis, by Pathogen Type, 2022

Figure 13: Global Gastrointestinal Pathogen Testing Market Value (US$ Mn) Share Analysis, by Pathogen Type, 2031

Figure 14: Global Gastrointestinal Pathogen Testing Market Attractiveness Analysis, by Pathogen Type, 2023–2031

Figure 15: Global Gastrointestinal Pathogen Testing Market Value (US$ Mn), by Bacteria, 2017‒2031

Figure 16: Global Gastrointestinal Pathogen Testing Market Value Share Analysis, by Bacteria, 2022 and 2031

Figure 17: Global Gastrointestinal Pathogen Testing Market Value (US$ Mn), by Viruses, 2017‒2031

Figure 18: Global Gastrointestinal Pathogen Testing Market Value Share Analysis, by Viruses, 2022 and 2031

Figure 19: Global Gastrointestinal Pathogen Testing Market Value (US$ Mn), by Parasites, 2017‒2031

Figure 20: Global Gastrointestinal Pathogen Testing Market Value Share Analysis, by Parasites, 2022 and 2031

Figure 21: Global Gastrointestinal Pathogen Testing Market Attractiveness Analysis, by Bacteria Pathogen Test, 2023–2031

Figure 22: Global Gastrointestinal Pathogen Testing Market Attractiveness Analysis, by Viruses Pathogen Test, 2023–2031

Figure 23: Global Gastrointestinal Pathogen Testing Market Attractiveness Analysis, by Parasite Pathogen Test, 2023–2031

Figure 24: Global Gastrointestinal Pathogen Testing Market Value (US$ Mn) Share Analysis, by Test Type, 2022 and 2031

Figure 25: Global Gastrointestinal Pathogen Testing Market Value (US$ Mn) Share Analysis, by Test Type, 2022

Figure 26: Global Gastrointestinal Pathogen Testing Market Value (US$ Mn) Share Analysis, by Test Type, 2031

Figure 27: Global Gastrointestinal Pathogen Testing Market Attractiveness Analysis, by Test Type, 2023–2031

Figure 28: Global Gastrointestinal Pathogen Testing Market Value (US$ Mn), by Molecular Tests, 2017‒2031

Figure 29: Global Gastrointestinal Pathogen Testing Market Value Share Analysis, by Molecular Tests, 2022 and 2031

Figure 30: Global Gastrointestinal Pathogen Testing Market Value (US$ Mn), by Culture, 2017‒2031

Figure 31: Global Gastrointestinal Pathogen Testing Market Value Share Analysis, by Culture, 2022 and 2031

Figure 32: Global Gastrointestinal Pathogen Testing Market Value (US$ Mn), by Biochemical Tests, 2017‒2031

Figure 33: Global Gastrointestinal Pathogen Testing Market Value Share Analysis, by Biochemical Tests, 2022 and 2031

Figure 34: Global Gastrointestinal Pathogen Testing Market Value (US$ Mn), by Culture, 2017‒2031

Figure 35: Global Gastrointestinal Pathogen Testing Market Value Share Analysis, by Culture, 2022 and 2031

Figure 36: Global Gastrointestinal Pathogen Testing Market Value (US$ Mn) Share Analysis, by Panel Type, 2022 and 2031

Figure 37: Global Gastrointestinal Pathogen Testing Market Value (US$ Mn) Share Analysis, by Panel Type, 2022

Figure 38: Global Gastrointestinal Pathogen Testing Market Value (US$ Mn) Share Analysis, by Panel Type, 2031

Figure 39: Global Gastrointestinal Pathogen Testing Market Attractiveness Analysis, by Panel Type, 2023–2031

Figure 40: Global Gastrointestinal Pathogen Testing Market Value (US$ Mn), by Syndromic Full Multiplex Panels, 2017‒2031

Figure 41: Global Gastrointestinal Pathogen Testing Market Value Share Analysis, by Syndromic Full Multiplex Panels, 2022 and 2031

Figure 42: Global Gastrointestinal Pathogen Testing Market Value (US$ Mn), by Others, 2017‒2031

Figure 43: Global Gastrointestinal Pathogen Testing Market Value Share Analysis, by Others, 2022 and 2031

Figure 44: Global Gastrointestinal Pathogen Testing Market Value (US$ Mn) Share Analysis, by End-user, 2022 and 2031

Figure 45: Global Gastrointestinal Pathogen Testing Market Value (US$ Mn) Share Analysis, by End-user, 2022

Figure 46: Global Gastrointestinal Pathogen Testing Market Value (US$ Mn) Share Analysis, by End-user, 2031

Figure 47: Global Gastrointestinal Pathogen Testing Market Attractiveness Analysis, by End-user, 2023–2031

Figure 48: Global Gastrointestinal Pathogen Testing Market Value (US$ Mn), by Hospitals, 2017‒2031

Figure 49: Global Gastrointestinal Pathogen Testing Market Value Share Analysis, by Hospitals, 2022 and 2031

Figure 50: Global Gastrointestinal Pathogen Testing Market Value (US$ Mn), by Others, 2017‒2031

Figure 51: Global Gastrointestinal Pathogen Testing Market Value Share Analysis, by Diagnostic Laboratories, 2022 and 2031

Figure 52: Global Gastrointestinal Pathogen Testing Market Value (US$ Mn), by Point-of-Care, 2017‒2031

Figure 53: Global Gastrointestinal Pathogen Testing Market Value Share Analysis, by Point-of-Care, 2022 and 2031

Figure 54: Global Gastrointestinal Pathogen Testing Market Value (US$ Mn), by Others, 2017‒2031

Figure 55: Global Gastrointestinal Pathogen Testing Market Value Share Analysis, by Others, 2022 and 2031

Figure 56: Global Gastrointestinal Pathogen Testing Market Value (US$ Mn) Share Analysis, by Region, 2022 and 2031

Figure 57: Global Gastrointestinal Pathogen Testing Market Value (US$ Mn) Share Analysis, by Region, 2022

Figure 58: Global Gastrointestinal Pathogen Testing Market Value (US$ Mn) Share Analysis, by Region, 2031

Figure 59: Global Gastrointestinal Pathogen Testing Market Attractiveness Analysis, by Region, 2023–2031

Figure 60: North America Gastrointestinal Pathogen Testing Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031

Figure 61: North America Gastrointestinal Pathogen Testing Market Value Share Analysis, by Country, 2022 and 2031

Figure 62: North America Gastrointestinal Pathogen Testing Market Attractiveness Analysis, by Country, 2023–2031

Figure 63: North America Gastrointestinal Pathogen Testing Market Value (US$ Mn) Share Analysis, by Pathogen Type, 2022 and 2031

Figure 64: North America Gastrointestinal Pathogen Testing Market Value (US$ Mn) Share Analysis, by Pathogen Type, 2022

Figure 65: North America Gastrointestinal Pathogen Testing Market Value (US$ Mn) Share Analysis, by Test Type, 2022 and 2031

Figure 66: North America Gastrointestinal Pathogen Testing Market Value (US$ Mn) Share Analysis, by Test Type, 2022

Figure 67: North America Gastrointestinal Pathogen Testing Market Value (US$ Mn) Share Analysis, by Panel Type, 2022 and 2031

Figure 68: North America Gastrointestinal Pathogen Testing Market Value (US$ Mn) Share Analysis, by Panel Type, 2022

Figure 69: North America Gastrointestinal Pathogen Testing Market Value (US$ Mn) Share Analysis, by End-user, 2022 and 2031

Figure 70: North America Gastrointestinal Pathogen Testing Market Value (US$ Mn) Share Analysis, by End-user, 2022

Figure 71: Europe Gastrointestinal Pathogen Testing Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031

Figure 72: Europe Gastrointestinal Pathogen Testing Market Value Share Analysis, by Country/Sub-region, 2022 and 2031

Figure 73: Europe Gastrointestinal Pathogen Testing Market Attractiveness Analysis, by Country/Sub-region, 2023–2031

Figure 74: Europe Gastrointestinal Pathogen Testing Market Value (US$ Mn) Share Analysis, by Pathogen Type, 2022 and 2031

Figure 75: Europe Gastrointestinal Pathogen Testing Market Value (US$ Mn) Share Analysis, by Pathogen Type, 2022

Figure 76: Europe Gastrointestinal Pathogen Testing Market Value (US$ Mn) Share Analysis, by Test Type, 2022 and 2031

Figure 77: Europe Gastrointestinal Pathogen Testing Market Value (US$ Mn) Share Analysis, by Test Type, 2022

Figure 78: Europe Gastrointestinal Pathogen Testing Market Value (US$ Mn) Share Analysis, by Panel Type, 2022 and 2031

Figure 79: Europe Gastrointestinal Pathogen Testing Market Value (US$ Mn) Share Analysis, by Panel Type, 2022

Figure 80: Europe Gastrointestinal Pathogen Testing Market Value (US$ Mn) Share Analysis, by End-user, 2022 and 2031

Figure 81: Europe Gastrointestinal Pathogen Testing Market Value (US$ Mn) Share Analysis, by End-user, 2022

Figure 82: Asia Pacific Gastrointestinal Pathogen Testing Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031

Figure 83: Asia Pacific Gastrointestinal Pathogen Testing Market Value Share Analysis, by Country/Sub-region, 2022 and 2031

Figure 84: Asia Pacific Gastrointestinal Pathogen Testing Market Attractiveness Analysis, by Country/Sub-region, 2023–2031

Figure 85: Asia Pacific Gastrointestinal Pathogen Testing Market Value (US$ Mn) Share Analysis, by Pathogen Type, 2022 and 2031

Figure 86: Asia Pacific Gastrointestinal Pathogen Testing Market Value (US$ Mn) Share Analysis, by Pathogen Type, 2022

Figure 87: Asia Pacific Gastrointestinal Pathogen Testing Market Value (US$ Mn) Share Analysis, by Test Type, 2022 and 2031

Figure 88: Asia Pacific Gastrointestinal Pathogen Testing Market Value (US$ Mn) Share Analysis, by Test Type, 2022

Figure 89: Asia Pacific Gastrointestinal Pathogen Testing Market Value (US$ Mn) Share Analysis, by Panel Type, 2022 and 2031

Figure 90: Asia Pacific Gastrointestinal Pathogen Testing Market Value (US$ Mn) Share Analysis, by Panel Type, 2022

Figure 91: Asia Pacific Gastrointestinal Pathogen Testing Market Value (US$ Mn) Share Analysis, by End-user, 2022 and 2031

Figure 92: Asia Pacific Gastrointestinal Pathogen Testing Market Value (US$ Mn) Share Analysis, by End-user, 2022

Figure 93: Latin America Gastrointestinal Pathogen Testing Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031

Figure 94: Latin America Gastrointestinal Pathogen Testing Market Value Share Analysis, by Country/Sub-region, 2022 and 2031

Figure 95: Latin America Gastrointestinal Pathogen Testing Market Attractiveness Analysis, by Country/Sub-region, 2023–2031

Figure 96: Latin America Gastrointestinal Pathogen Testing Market Value (US$ Mn) Share Analysis, by Pathogen Type, 2022 and 2031

Figure 97: Latin America Gastrointestinal Pathogen Testing Market Value (US$ Mn) Share Analysis, by Pathogen Type, 2022

Figure 98: Latin America Gastrointestinal Pathogen Testing Market Value (US$ Mn) Share Analysis, by Test Type, 2022 and 2031

Figure 99: Latin America Gastrointestinal Pathogen Testing Market Value (US$ Mn) Share Analysis, by Test Type, 2022

Figure 100: Latin America Gastrointestinal Pathogen Testing Market Value (US$ Mn) Share Analysis, by Panel Type, 2022 and 2031

Figure 101: Latin America Gastrointestinal Pathogen Testing Market Value (US$ Mn) Share Analysis, by Panel Type, 2022

Figure 102: Latin America Gastrointestinal Pathogen Testing Market Value (US$ Mn) Share Analysis, by End-user, 2022 and 2031

Figure 103: Latin America Gastrointestinal Pathogen Testing Market Value (US$ Mn) Share Analysis, by End-user, 2022

Figure 104: Middle East & Africa Gastrointestinal Pathogen Testing Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031

Figure 105: Middle East & Africa Gastrointestinal Pathogen Testing Market Value Share Analysis, by Country/Sub-region, 2022 and 2031

Figure 106: Middle East & Africa Gastrointestinal Pathogen Testing Market Attractiveness Analysis, by Country/Sub-region, 2023–2031

Figure 107: Middle East & Africa Gastrointestinal Pathogen Testing Market Value (US$ Mn) Share Analysis, by Pathogen Type, 2022 and 2031

Figure 108: Middle East & Africa Gastrointestinal Pathogen Testing Market Value (US$ Mn) Share Analysis, by Pathogen Type, 2022

Figure 109: Middle East & Africa Gastrointestinal Pathogen Testing Market Value (US$ Mn) Share Analysis, by Test Type, 2022 and 2031

Figure 110: Middle East & Africa Gastrointestinal Pathogen Testing Market Value (US$ Mn) Share Analysis, by Test Type, 2022

Figure 111: Middle East & Africa Gastrointestinal Pathogen Testing Market Value (US$ Mn) Share Analysis, by Panel Type, 2022 and 2031

Figure 112: Middle East & Africa Gastrointestinal Pathogen Testing Market Value (US$ Mn) Share Analysis, by Panel Type, 2022

Figure 113: Middle East & Africa Gastrointestinal Pathogen Testing Market Value (US$ Mn) Share Analysis, by End-user, 2022 and 2031

Figure 114: Middle East & Africa Gastrointestinal Pathogen Testing Market Value (US$ Mn) Share Analysis, by End-user, 2022

Copyright © Transparency Market Research, Inc. All Rights reserved